Department of Neurosurgery, University of Helsinki and Helsinki University Hospital, P.O. Box 266, Fin-00029-HUS, Helsinki, Finland.
Department of Neurosurgery, Maastricht University Medical Center, Maastricht, The Netherlands.
J Neurooncol. 2021 Mar;152(1):195-204. doi: 10.1007/s11060-020-03693-4. Epub 2021 Jan 21.
Surgical resection of intracranial meningiomas in patients that are 80 years old and older, i.e. very old patients, is increasingly considered. Meningiomas with a largest diameter of at least 5 cm-'giant meningiomas'-form a distinct entity, and their surgical resection is considered more difficult and prone to complications. Here, we evaluated functional outcome, morbidity and mortality, and the prognostic value of tumor size in very old patients who underwent resection of giant supratentorial meningiomas.
We retrospectively reviewed clinical and radiological data, functional performance (Karnofsky Performance Score), histopathological diagnosis and complications of very old patients who underwent surgery of a supratentorial meningioma at the Helsinki University Hospital between 2010 and 2018.
We identified 76 very old patients, including 28 with a giant meningioma. Patients with a giant meningioma suffered from major complications more commonly than those with a non-giant meningioma (36% vs. 17%, p = 0.06), particularly from postoperative intracranial hemorrhages (ICH). At the 1-year follow-up, functional performance and mortality rate were comparable between patients with giant meningiomas and those with non-giant meningiomas. An exceptionally high rate of giant meningiomas were diagnosed as atypical meningiomas (WHO II) at an (11 out of 28 cases).
Giant meningioma surgery entails a high complication rate in frail, very old patients. The prevention of postoperative ICH in this specific patient group is of utmost importance. An atypical histopathology was notably frequent among very old patients with a giant meningioma, which should be taken into account when planning the surgical strategy.
对于 80 岁及以上的颅内脑膜瘤患者,即非常高龄患者,越来越多地考虑进行手术切除。直径至少为 5 厘米的脑膜瘤-“巨大脑膜瘤”-构成了一个独特的实体,其手术切除被认为更困难且容易发生并发症。在这里,我们评估了在接受巨大幕上脑膜瘤切除术的非常高龄患者中的功能结果、发病率和死亡率,以及肿瘤大小的预后价值。
我们回顾性地审查了 2010 年至 2018 年间在赫尔辛基大学医院接受幕上脑膜瘤手术的非常高龄患者的临床和影像学数据、功能表现(卡诺夫斯基表现评分)、组织病理学诊断和并发症。
我们确定了 76 名非常高龄患者,其中 28 名患有巨大脑膜瘤。患有巨大脑膜瘤的患者比患有非巨大脑膜瘤的患者更常发生重大并发症(36%比 17%,p=0.06),特别是术后颅内出血(ICH)。在 1 年随访时,患有巨大脑膜瘤和非巨大脑膜瘤的患者的功能表现和死亡率相当。非常高龄患者中巨大脑膜瘤的异常高比例被诊断为非典型脑膜瘤(WHO II)(28 例中有 11 例)。
在体弱的非常高龄患者中,巨大脑膜瘤手术的并发症发生率很高。在该特定患者群体中,预防术后 ICH 至关重要。非常高龄患者中巨大脑膜瘤的非典型组织病理学明显更为常见,在制定手术策略时应考虑这一点。